KIRSTYN KAMEG: Open Payments
NPI 1851332233 · BRIDGEVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$60,445 in 132 payments from 7 companies in 2025. Trend: 2023 $30,239 · 2024 $41,730 · 2025 $60,445
Honoraria: $53,300Travel & lodging: $5,082Food & beverage: $2,062
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 79 | $59,710 |
| ABBVIE INC. | 26 | $344 |
| Neurocrine BioSciences, Inc. | 3 | $187 |
| Supernus Pharmaceuticals, Inc. | 21 | $143 |
| Collegium Pharmaceutical, Inc. | 1 | $23 |
| Bausch Health US, LLC | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: Auvelity, VRAYLAR, INGREZZA, Qelbree, Jornay PM, APLENZIN, REXULTI.
Industry payments across PA — which companies pay providers there.
